Skip to content

TAG Comment in Response to Proposed Rulemaking: Visas: Ineligibility Based on Public Charge Grounds

  • Dorrit Walsh
As an organization dedicated to ensuring equitable access to critical health services to individuals and communities affected by HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV), Treatment Action Group (TAG) strongly opposes the proposed changes regarding “public charge,” published in the Federal Register on October 11, 2019 (the proposed rule).
Read more

Comment in Response to Proposed Rulemaking: Regulation to Require Drug Pricing Transparency

  • Chad Cipiti
On October 18, 2018, the Trump Administration proposed regulations at the Centers for Medicare and Medicaid Services (CMS) to require publication of the list price of any prescription drug or biological product paid by Medicare or Medicaid in direct-to-consumer (DTC) advertising. While TAG applauds the administration's attention to curbing drastic increases in drug prices, list price transparency in DTC advertisements alone will not be a sufficient measure to bring necessary change.
Read more
Back To Top